These experiments confirmed variable levels of PRAME-pHLA complexes between cell lines (Fig. 5d); melanoma MEL624 cells, which have high PRAME expression genotype, had abundant complexes on the plasma membrane, whereas glioblastoma CHP212 cells did not. This evidence concerns the gene PRAME and glioblastoma.